PLX
Protalix Biotherapeutics
Description:
Protalix Biotherapeutics Inc. is a biopharmaceutical company headquartered in Karmiel, Israel, dedicated to developing and commercializing innovative recombinant therapeutic proteins through its proprietary ProCellEx plant cell-based expression system. The company is strategically focused on addressing unmet medical needs across emerging markets, notably in Israel, Brazil, and Latin America, with a diverse pipeline aimed at treating various conditions. With a strong commitment to innovation and expansion, Protalix is well-positioned to capitalize on growth opportunities in the biotechnology sector, offering significant potential for enhanced patient outcomes and value creation for institutional investors.
Address:
2 UNIVERSITY PLAZA, HACKENSACK, NJ, UNITED STATES, 07601
Fiscal year end:
December
Market capitalization:
$166 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-82%
How much will you get:
$176
Prices dates:
31-12-2015: $10.20 and 31-12-2025: $1.80